Table 4.
Factors Associated with Longitudinal Scores for Well-Being Outcomes1
| Physical Well-being | Functional Well-being | Emotional Well-being | |
|---|---|---|---|
| Covariates | β (95% CI) | β (95% CI) | β (95% CI) |
| Age, per 1 year increase | .01 (−.10 – .11) | .05 (−.09 – .19) | .02 (−.08 – .11) |
| CogAge vs TLC | 3.04 (1.66 – 4.43)*** | .06 (−1.69 – 1.82) | 6.49 (5.25 – 7.74)*** |
| High school vs. <=HS education | 10.2 (−.27 – 2.30) | 1.63 (.00 – 3.26)* | .87 (−.28 – 2.02) |
| IADL, per increase in limitation | −.74 (−1.23 - −.24)** | .89 (−1.52 – .25)** | −.33 (−.78 – .12) |
| Hormone Therapy (Yes versus No) | 1.02 (.00 – 2.05) | 1.55 (.25 – 2.84)* | .61 (−.31 – 1.53) |
| Impact of Taxanes | |||
| Taxane vs. non taxane regimen | .89 (−.66 – 2.23) | −.03 (−1.72 – 1.71) | −.50 (−1.64 – .64) |
| Time effect, pre-treatment to 12-month | .35 (−.53 – 1.24) | 1.02 (.08 – 1.97)* | 1.38 (.83 – 1.93)*** |
| Taxane group × pre-treatment to 12-month | −.62 (−2.36 – 1.12) | −.20 (−2.08 – 1.68) | −.60 (−1.70 – .50) |
| Time effect, 12- to 36-months | .47 (−.16 – 1.10) | .39 (−.28 – 1.08) | .06 (−.34 – .45) |
| Taxane group × 12- to 36 months | −.15 (−1.36 – 1.07) | −.17 (−1.47 – 1.14) | −.02 (−.78 – .74) |
*
p < .05,
**
p < .01,
***
p < .001
1
Results for piecewise multilevel models modeling change in well-being outcomes. Sample reference group is TLC; Education reference group is high school completion; treatment group reference is chemotherapy with taxane.